Cargando…
Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia
OBJECTIVE: This study investigated the efficacy, safety, tolerability, and pharmacokinetics of a novel cholesterol absorption inhibitor, FM-VP4, comprising disodium ascorbyl sitostanol phosphate (DASP) and disodium ascorbyl campestanol phosphate (DACP). METHODS: In phase 1, 30 men received a single...
Autores principales: | Vissers, Maud N., Trip, Mieke D., Pritchard, P. Haydn, Tam, Patrick, Lukic, Tatjana, de Sain-van der Velden, Monique G., de Barse, Martina, Kastelein, John J. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426926/ https://www.ncbi.nlm.nih.gov/pubmed/18320185 http://dx.doi.org/10.1007/s00228-008-0462-1 |
Ejemplares similares
-
The effect of two novel cholesterol-lowering agents, disodium ascorbyl phytostanol phosphate (DAPP) and nanostructured aluminosilicate (NSAS) on the expression and activity of P-glycoprotein within Caco-2 cells
por: Sachs-Barrable, Kristina, et al.
Publicado: (2014) -
Phytosterols, Phytostanols, and Lipoprotein Metabolism
por: Gylling, Helena, et al.
Publicado: (2015) -
Pharmacokinetics and Tolerability of Single and Multiple Intravenous Doses of Cefotetan Disodium in Healthy Chinese Volunteers
por: Liu, Jian, et al.
Publicado: (2020) -
Formulation and Characterization of Phytostanol Ester Solid Lipid Nanoparticles for the Management of Hypercholesterolemia: An ex vivo Study
por: Shrestha, Sony Chandi, et al.
Publicado: (2021) -
Ascorbyl Palmitate Hydrogel for Local, Intestinal Delivery of Macromolecules
por: Zhai, Jinyi, et al.
Publicado: (2018)